Phase I trial of CBLB 612 in healthy volunteers

Trial Profile

Phase I trial of CBLB 612 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs CBLB 612 (Primary)
  • Indications Stem cell mobilisation
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 13 Jul 2015 Results published in Cleveland BioLabs Media Release.
    • 06 May 2015 Status changed from active, no longer recruiting to completed according to a Cleveland BioLabs media release.
    • 16 Mar 2015 According to a Cleveland BioLabs media release, data from this trial are expected to be reported in second quarter of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top